However, given that the expression of ELF3 is upregulated in several K-Ras mutant LUADs and lung squamous cell carcinomas (LSCCs), whether auranofin has therapeutic potential to repress ELF3 through inhibition of PKCί activity in EGFR mutant LUAD remains unclear [19]. This evidence concerns the gene KRAS and squamous cell lung carcinoma.